Clinical Trials
11 trialsNCT05645107 2026-04-13
EXCELL
Grifols Therapeutics LLC
Phase 3 Recruiting
NCT07051525 2025-12-15
ELSA-Adult
Peter MacCallum Cancer Centre, Australia
Phase NA Recruiting
NCT05611905 2025-12-12
Biodistribution and Pathophysiology Study of 11C-para-aminobenzoic Acid
Johns Hopkins University
Completed
NCT05153694 2024-09-19
Infectious Complications After Cystectomy: A Prospective Observational Study
Ludwig-Maximilians - University of Munich
Recruiting
NCT06025682 2024-04-11
INO-FIRST
Gruppo Italiano Malattie EMatologiche dell'Adulto
Unknown
NCT01817075 2021-06-22
Chlorhexidine Gluconate Cleansing in Preventing Central Line Associated Bloodstream Infection and Acquisition of Multi-drug Resistant Organisms in Younger Patients With Cancer or Undergoing Donor Stem Cell Transplant
Children's Oncology Group
Phase 3 Completed
NCT03301597 2021-03-30
LAUNCH
Nohla Therapeutics, Inc.
Phase 2 Terminated
NCT01371656 2020-12-07
Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation
Children's Oncology Group
Phase 3 Completed
NCT02753387 2018-12-20
ORAL-ISO
Rennes University Hospital
Phase 3 Completed
NCT02544230 2015-09-09
Granulocyte Transfusions in Hematological Patients With Febrile Neutropenia
Sorveglianza Epidemiologica Infezioni Fungine Emopatie Maligne
Completed
NCT00167999 2007-03-15
Study Evaluating Piperacillin-Tazobactam on Certain Bacteria in Hematology and Oncology Units
Wyeth is now a wholly owned subsidiary of Pfizer
Completed